Clinical Trial

Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life

Name: Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life — clinical trial record (NCT06759077)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

If this study has a cardio protective effect it will affect the mortality and morbidity of advanced CKD patients and improve their quality of life

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-12-30; most recent amendment 2025-01-07.

Trial Details

NCT Number	NCT06759077
Lead Sponsor	Al-Azhar University
Conditions	Kidney Diseases
Enrollment	126 participants
Start Date	2024-12-28
Primary Completion	2024-12-28 (estimated)
Study Completion	2025-12-28 (estimated)
Updated on ClinicalTrials.gov	2025-01-08